bpc 157 pharmacokinetics half life human Multifunctionality and Possible Medical Application of the Peptide—Literature and Patent Review Therapeutic peptides and proteins: Status
Description
Serious reactions are rare but possible
K.RuegerD
Although it entered phase 1 trials in consideration as a treatment of ulcerative colitis, it has not been approved by the US Food and Drug Administration (FDA) for medical use, and data on human subjects is lacking
Kesimptas pens/syringes are designed for one-time use only
